Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 5,021–5,040 of 17,299 recalls

FDA Recall Terminated Historical recordClass II

Children's Pain & Fever Bubblegum Flavored Acetaminophen Suspension (160mg/5ml), 4 fl oz (118 mL) per bottle, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716. NDC: 49035-313-26

by Perrigo Company PLC

Reason
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Acetaminophen Oral Suspension Grape Flavor, 160 mg per 5 mL, 16 fl oz (473 mL) per bottle, Distributed by Perrigo, Allegan, MI 49010. NDC: 50941-009-43

by Perrigo Company PLC

Reason
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-865-60

by Dr. Reddy's Laboratories, Inc.

Reason
Failed stability specifications
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-465-62

by Dr. Reddy's Laboratories, Inc.

Reason
Failed stability specifications
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-305-62

by Dr. Reddy's Laboratories, Inc.

Reason
Failed stability specifications
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01

by RISING PHARMACEUTICALS

Reason
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Prevantics (chlorhexidine gluconate and isopropyl alcohol) Swabstick, 3.15% w/v and 70% v/v, packaged as a) One Swabstick, 0.054 fl. oz. (1.6 mL) Each in a pouch, NDC 10819-4077-1; 50 Individual Swabsticks per carton, 10 boxes of 50 Individual Swabsticks per case, REORDER NO. S40750, NDC 10819-4077-4; b) One Swabstick, 0.054 fl. Oz. (1.6 mL) Each in a pouch, 500 Individual Swabsticks per case, REORDER NO. S32450, NDC 10819-4077-2; c) One Swabstick, 0.054 fl. Oz. (1.6 mL) Each in a pouch, 500 Individual Swabsticks per case, REORDER NO. S42850, NDC 10819-4077-3; Professional Disposables International, Inc., Orangeburg, NY 10962-1376.

by Professional Disposables International, Inc.

Reason
cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Prevantics (chlorhexidine gluconate and isopropyl alcohol) Swab, 3.15% w/v and 70% v/v, packaged as a) One Swab, 0.034 fl. Oz. (1 mL) Each in a pouch, 100 Individual Swabs per carton, 10 boxes of 100 Individual Swabs per case, REORDER NO. B10800, NDC 10819-1080-1; b) One Swab, 0.034 fl. oz. (1 mL) Each in a pouch, 3000 Individual Swabs per case, REORDER NO. B11400, NDC 10819-1080-2; Professional Disposables International, Inc., Orangeburg, NY 10962-1376.

by Professional Disposables International, Inc.

Reason
cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Prevantics (chlorhexidine gluconate and isopropyl alcohol) Maxi Swabstick, 3.15% w/v and 70% v/v, packaged as a) One Maxi Swabstick, 0.172 fl. Oz. (5.1 mL) Each in a pouch, 30 Individual Maxi Swabsticks per carton, 10 boxes of 30 Individual Swabsticks per case, NDC 10819-4076-4, REORDER NO. S41950; b) One Maxi Swabstick, 0.172 fl. Oz. (5.1 mL) Each in a pouch, 300 Individual Swabsticks per case, NDC 10819-4076-3, REORDER NO. S27350; Professional Disposables International, Inc., Orangeburg, NY 10962-1376.

by Professional Disposables International, Inc.

Reason
cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.
Published
March 2, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.

by Teligent Pharma, Inc.

Reason
Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.

by Revive Rx LLC dba Revive Rx Pharmacy

Reason
Non-sterility; bacterial contamination identified as Paenibacillus lautus.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white rod in a Tyvek polyethylene pouch, Rx Only, Manufactured by Teva Women's Health Inc. a subsidiary of Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 51285-204-01

by CooperSurgical, Inc

Reason
Non-sterility
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.

by Celebrate Today

Reason
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

THE RED PILL, EXTRA STRENGTH capsules, 800 mg, packaged in 10-count blisters packaged in a carton, ASIN B0847BSQQ5, Barcode X002G5GMJ1.

by Your Favorite Shop

Reason
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100 Orthodox St. Philadephia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-648-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 1.0 mg, packaged in a) 100-count bottles (NDC 67253-902-10), b) 500-count bottles (NDC 67253-902-50), and c) 1000-count bottles (NDC 67253-902-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count bottles (NDC 67253-901-50), and c) 1000-count bottles (NDC 67253-901-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b) 500-count bottles (NDC 67253-900-50), and c) 1000-count bottles (NDC 67253-900-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.